Economy

The Geron Corp. (GERN) Issues Earnings Results, Beats Estimates By $0.04 EPS

What Historical Figures Say About Geron Corporation (NASDAQ: GERN)? For the current quarter Geron Corporation (NASDAQ:GERN) has high EPS estimates of $-0.04 in contradiction of low EPS estimates of $-0.05. The biopharmaceutical company reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.05) by $0.01. The value of the company's investment in Geron Corporation went from $97,282,000 to $3,172,000 a change of $94,110,000 since the last quarter.

Analysts have given a mean recommendation of 2.70 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range). Geron Corporation presently has an average rating of "Hold" and a consensus target price of $3.75.

Geron Corporation (GERN) has risen 4.28% since then. BidaskClub downgraded shares of Geron Corporation from a "hold" rating to a "sell" rating in a research report on Saturday, August 5th.

Taking a broader look at the analyst consensus, according to 2 analysts Geron Corporation (NASDAQ:GERN)'s price will reach at $3.75 during 52 weeks. The stock ended last trade at $1.95 a share and the price is up more than -5.80% so far this year.

According to 3 stock analysts, Geron Corporation, is being kept at an average Hold, rating, with at least 17.53% of shares outstanding that are now legally short sold. The volume of FRED witnessed a shift from 2.9 million shares, based on a 50-day average, to 0.93 million shares.

BTIG Research "Initiates Coverage on" Geron Corporation (NASDAQ:GERN) in a research note issued to investors on 8/19/16 to Neutral. This works out to a decrease of -10.53% compared to last year's earnings. The stock now has a consensus rating of "Hold" and a consensus price target of $3.75. If you are viewing this report on another site, it was illegally copied and reposted in violation of United States and worldwide copyright and trademark law. The original version of this article can be read at https://weekherald.com/2017/11/13/geron-corporations-gern-hold-rating-reaffirmed-at-needham-company-llc.html.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. BlackRock Investment Management LLC boosted its stake in Geron Corp.by 4.0% in the second quarter. Parametric Portfolio Associates LLC boosted its holdings in shares of Geron Corporation by 59.4% in the 2nd quarter. IHT Wealth Management LLC bought a new position in shares of Geron Corporation in the second quarter worth about $122,000. Insider ownership during the latest quarter increased by a net of 18206 shares, indicating that GERN's key executives are feeling more bullish about the stock than they did three months ago. Janney Montgomery Scott LLC now owns 132,200 shares of the biopharmaceutical company's stock valued at $354,000 after buying an additional 65,100 shares in the last quarter.

Currently Geron Corporation (NASDAQ:GERN)'s shares owned by insiders are 0.1%, whereas shares owned by institutional owners are 39.2%.

Geron Corporation (Geron), launched on November 28, 1990, is a biopharmaceutical company, which supports the clinical stage development of a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies by Janssen Biotech, Inc. Using its nucleic acid chemistry, Geron designed Imetelstat to be an oligonucleotide that binds with high affinity to the ribonucleic acid (RNA) template of telomerase, thereby directly inhibiting telomerase activity.



Like this

loading...
loading...

Latest


14 November 2017
Minerva Punjab, Mohun Bagan to kickstart 2017-18 I-League season
However, the release of the fixtures just 11 days ahead of the actual start of the league does not bode well for the tournament. For the first time since the inception of ISL in 2014, the franchise league and I-League will be held concurrently this season.

14 November 2017
Russian Federation and US Analyze UN Deployment in Ukraine
Volker and Surkov earlier held talks on October 7 in Belgrade and on August 21 in the Belarusian capital, Minsk. Meanwhile, a top USA diplomat was set to visit Ukraine this week at the end of a 10-day trip to Europe.

14 November 2017
Bhopal gangrape case: HC seeks status report on action against cops
Taking suo motu cognizance of media reports, the high court had issued notices to the chief secretary and the DGP. While her father works with the Railway Protection Force, her mother is with the state police.

14 November 2017
Growth Analysis of Exxon Mobil Corporation (XOM)
The Folger Nolan Fleming Douglas Capital Management Inc holds 188,747 shares with $15.24M value, down from 243,908 last quarter. Walter & Keenan Financial Consulting Company decreased Exxon Mobil Corp (XOM) stake by 4.25% reported in 2017Q2 SEC filing.

14 November 2017
Are Traders Shorting Medical Properties Trust, Inc. (NYSE:MPW) Shares?
The real estate investment trust reported $0.33 EPS for the quarter, topping the Zacks' consensus estimate of $0.32 by $0.01. It improved, as 19 investors sold MPW shares while 71 reduced holdings. 57 funds opened positions while 139 raised stakes.

14 November 2017
I-5 in Del Mar reopens after deadly crash
About half a mile south of that collision, a pickup truck crashed into several vehicles about 4:45 a.m. Moments later, a black Mercedes hit the Toyota, which was still in traffic lanes.

14 November 2017
Enphase Energy Inc (NASDAQ:ENPH) Institutional Investors Sentiment Drops in 2017 Q2
The Firm is engaged in designing, developing, manufacturing and selling microinverter systems for the solar photovoltaic industry. ValuEngine raised shares of Enphase Energy from a strong sell rating to a sell rating in a report on Wednesday, September 27th.

14 November 2017
Pakistani teen arrested for sexually assaulting chicken
The puppy "died due to excessive bleeding from private parts and shock", India Today reported quoting the post-mortem report. He also named two locals as eyewitnesses in his complaint.

14 November 2017
Former Pharmaceutical Company Executive Picked to Run HHS
The HHS is responsible for advising the President on matters of health, welfare, and income security programmes. He would also help the Trump administration to dismantle Obamacare and crack down on drug prices.

14 November 2017
Outdoor pollution behind 6% disease burden
A lot less number of people are burdened with communicable diseases, but the burden of non-communicable diseases is rising. In all, scientists have identified 333 disease conditions and 84 risk factors for all the states in India .